Approved at the beginning of 2016, US revenues of the cheaper competitor, Basaglar, were around $115 million in Q3, almost double the previous quarter thanks to a strong launch. Lantus sales are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback